Shanghai Pharmaceuticals Holding Co Ltd

Price Chart

Risk-Adjusted Performance

Also Listed On

Shanghai Pharmaceuticals Holding Co Ltd (2607) Price Performance

Shanghai Pharmaceuticals Holding Co Ltd (2607) trades on Hong Kong Stock Exchange in HKD. The company is classified in the Healthcare sector under the Medical Distribution industry. The stock currently trades at HKD11.15, down 1.85% from the previous close.

Over the past year, 2607 has traded between a low of HKD9.75 and a high of HKD12.69. The stock has gained 1.2% over this period. It is currently 12.2% below its 52-week high.

Shanghai Pharmaceuticals Holding Co Ltd has a market capitalization of $65.20B, with a price-to-earnings ratio of 8.22 and a dividend yield of 2.35%.

About Shanghai Pharmaceuticals Holding Co Ltd

Shanghai Pharmaceuticals Holding Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical and healthcare products in China and internationally. It operates through four segments: Production, Distribution, Retail, and Others. The company offers chemical and biological drugs, Chinese medicine, health care products, and medical devices to treat immunology, psychiatric and neurological, tumor, cardiovascular, digestive metabolism, psychoneurotic, neoplasm, respiratory system, and anti-infection diseases, as well as invests in equity. It also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, the company engages in the operation of a network of retail pharmacy stores. Shanghai Pharmaceuticals Holding Co., Ltd. was incorporated in 1994 and is headquartered in Shanghai, China.